Markets
Security | Price ▼ | % | Buy | Sell | Target price | Potential |
---|---|---|---|---|---|---|
Allergy Therapeutics PLC |
€0.053
20.09.24 |
6.000% | 0 | 0 | - | - |
Lifespot Health Ltd |
€0.051
18.08.21 |
- | 0 | 0 | - | - |
Zosano Pharma Corp. |
€0.050
28.10.22 |
- | 0 | 0 | - | - |
Alliqua BioMedical Inc |
€0.050
27.01.22 |
- | 0 | 0 | - | - |
Medmira Inc. |
€0.050
20.09.24 |
-2.940% | 0 | 0 | - | - |
Resonance Health Ltd |
€0.050
30.09.21 |
-8.330% | 0 | 0 | - | - |
Therma Bright Inc. |
€0.048
20.09.24 |
13.100% | 0 | 0 | - | - |
Destiny Pharma |
€0.048
12.08.24 |
28.380% | 0 | 0 | - | - |
Generex Biotechnology |
€0.047
21.02.22 |
4.940% | 0 | 0 | - | - |
Sirona Biochem Corp. |
€0.046
20.09.24 |
4.170% | 0 | 0 | - | - |
IntelliPharmaCeutics International Inc. |
€0.045
06.03.24 |
-13.590% | 0 | 0 | - | - |
INSYS Therapeutics Inc |
€0.042
19.02.20 |
5.000% | 0 | 0 | - | - |
Kazia Therapeutics |
€0.042
10.11.23 |
-25.220% | 0 | 0 | - | - |
Avalo Therapeutics Inc. |
€0.041
28.12.23 |
2.500% | 2 | 0 | - | - |
Elanix Biotechnologies AG |
€0.041
04.08.23 |
-41.180% | 0 | 0 | - | - |
Quantum Genomics S.A. |
€0.040
20.09.24 |
7800.000% | 0 | 0 | - | - |
Resverlogix Corp |
€0.036
20.09.24 |
- | 0 | 0 | - | - |
Elite Pharmaceut. |
€0.035
30.09.21 |
-4.110% | 0 | 0 | - | - |
Proteome Sciences |
€0.035
20.09.24 |
- | 0 | 0 | - | - |
Cellmid Ltd |
€0.034
30.09.21 |
7.940% | 0 | 0 | - | - |
ReNeuron Group plc |
€0.034
06.02.24 |
- | 0 | 0 | - | - |
Aravive, Inc. |
€0.033
29.01.24 |
-16.670% | 0 | 0 | - | - |
Omega Diagnostics Group plc |
€0.030
20.09.24 |
- | 0 | 0 | - | - |
Auscann Group Holdings Ltd |
€0.028
12.11.23 |
-10.170% | 0 | 0 | - | - |
Acarix AB |
€0.027
20.09.24 |
23.720% | 0 | 0 | - | - |
Titan Medical Inc. |
€0.027
20.09.24 |
-35.370% | 0 | 0 | - | - |
ViewRay Inc |
€0.025
03.08.23 |
2400.000% | 0 | 0 | - | - |
Active Biotech AB |
€0.024
20.09.24 |
23.980% | 0 | 0 | - | - |
Invictus MD Strategies |
€0.023
03.03.20 |
-31.820% | 1 | 0 | - | - |
Emerald Health Therapeutics Inc |
€0.022
03.03.23 |
- | 0 | 0 | - | - |